Tanvex BioPharma Inc (6541) — Tangible Net Worth Ratio
Tanvex BioPharma Inc (6541) has a Tangible Net Worth Ratio of 91.5% as of December 2025. This metric is calculated by deducting intangible assets (NT$485.32 Million) from net assets (NT$5.69 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Tanvex BioPharma Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tanvex BioPharma Inc Tangible Net Worth Ratio (2013–2025)
This chart shows how Tanvex BioPharma Inc's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 91.5%, reflecting net assets of NT$5.69 Billion with intangible assets of NT$485.32 Million TWD. See 6541 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Tanvex BioPharma Inc (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Tanvex BioPharma Inc from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Tanvex BioPharma Inc market capitalisation.
| Year | Tangible NW Ratio | Net Assets (TWD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 91.5% | NT$5.69 Billion | NT$485.32 Million | NT$7.96 Billion | ▼ -7.7 pp |
| 2024 | 99.2% | NT$893.31 Million | NT$7.07 Million | NT$2.74 Billion | ▼ -0.4 pp |
| 2023 | 99.6% | NT$821.11 Million | NT$3.38 Million | NT$2.76 Billion | ▲ +0.5 pp |
| 2022 | 99.1% | NT$1.39 Billion | NT$12.07 Million | NT$3.42 Billion | ▼ -0.5 pp |
| 2021 | 99.6% | NT$2.79 Billion | NT$10.17 Million | NT$4.71 Billion | ▲ +0.1 pp |
| 2020 | 99.5% | NT$2.62 Billion | NT$11.96 Million | NT$4.37 Billion | ▲ +0.1 pp |
| 2019 | 99.5% | NT$3.03 Billion | NT$15.93 Million | NT$3.57 Billion | ▼ -0.1 pp |
| 2018 | 99.6% | NT$4.21 Billion | NT$18.17 Million | NT$4.48 Billion | ▲ +0.2 pp |
| 2017 | 99.3% | NT$3.75 Billion | NT$24.63 Million | NT$3.97 Billion | ▲ +1.0 pp |
| 2016 | 98.4% | NT$3.57 Billion | NT$57.66 Million | NT$3.87 Billion | ▲ +2.5 pp |
| 2015 | 95.9% | NT$1.45 Billion | NT$59.75 Million | NT$1.57 Billion | ▲ +3.8 pp |
| 2014 | 92.1% | NT$589.64 Million | NT$46.48 Million | NT$654.74 Million | ▲ +2.6 pp |
| 2013 | 89.5% | NT$403.64 Million | NT$42.50 Million | NT$487.27 Million | — |